Amendment No. 1 to Series A Preferred Stock Redemption AgreementSeries a Preferred Stock Redemption Agreement • June 26th, 2023 • Mosaic ImmunoEngineering Inc. • Biological products, (no disgnostic substances)
THIS Amendment No. 1 to the Series A Preferred Stock Redemption Agreement (the “Amendment No. 1”) is made this 21st day of June, 2023 (“Effective Date”) by and among (i) Mosaic ImmunoEngineering, Inc., a Delaware corporation ("Mosaic"), f/k/a Patriot Scientific Corporation and (ii) Holocom, Inc., a California corporation (“Holocom”) (collectively referred to as the “Parties”). Capitalized terms not otherwise defined herein shall have the meanings ascribed to such terms in the Redemption Agreement dated July 6, 2022 or Restated Articles of Incorporation of Holocom filed February 15, 2007 with the Secretary of State of the State of California, as amended to date (the "Articles of Incorporation").
